ImmunityBio, Inc.
IBRX • NASDAQ
ImmunityBio, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Richard Gerald Adcock, with a market cap of $7.7B.
Market Cap$7.7B
Employees628.0
CEORichard Gerald Adcock
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 11, 2026 · In 4 weeksQ1 2026
Financials
ImmunityBio, Inc. FAQ
Common questions about ImmunityBio, Inc.
ImmunityBio, Inc. is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $42.3M.
ImmunityBio, Inc. has approximately 628 employees.